SINGAPORE’S LARGEST AND LEADING CO-WORKING LABORATORY & OFFICE SPACE

Hingge brings over 25 years’ experience in venture capital, investment banking as well as corporate and business development.

He was most recently a Senior Advisor at WuXi Healthcare Ventures where he co-founded LifeMine Therapeutics. Prior to that, he was a Partner at Fidelity Biosciences (now F-Prime Capital) where he was involved with various venture stage investments in the biotechnology and medical technology sectors in the United States and Asia. Before joining Fidelity, Hingge was a Managing Director in the Private Equity Group at Lehman Brothers and was responsible for their principal investment activities in the private and public sectors of the healthcare industry. From 1998 to 2001 he held the position of Partner at Schroder Ventures Life Sciences and directed their US investment activities in the life sciences and therapeutics sectors.

Prior to Schroder Ventures, Hingge was at Robertson Stephens and at Lehman Brothers, both in the Healthcare Investment Banking Groups. He also worked at Chiron Corporation and Gensia, Inc in the areas of business development and strategic planning.

Hingge received an MD degree from Yale University School of Medicine and was trained in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. Hingge also received an MBA degree from Harvard Business School.

Hingge has served on the Board of Directors of a number of privately-held biopharmaceutical and medical device companies. He currently serves on the Board of RootPath Genomics, Inc.

Tim is a world leader in the field of synthetic biology and has co-founded multiple successful venture-backed platform biotech companies, including Synlogic, Corvium, and Senti BioSciences, raising over $100MM in VC funding from Atlas, NEA, 8VC, the Gates Foundation, Orbimed, Deerfield, and Flybridge. At MIT, Timothy leads the Synthetic Biology Group and serves as an Associate Professor of Biological Engineering and Electrical Engineering and Computer Science. He is an Associate Member of the Broad Institute of MIT and Harvard. Timothy’s numerous accolades include the NIH New Innovator Award, the US Presidential Early Career Award for Scientists and Engineers, and the Ellison Medical Foundation New Scholar in Aging Award. He was also selected as a Siebel Scholar and Kavli Fellow by the National Academy of Sciences. Tim was nominated as the 2018 Xconomy Scientific Founder of the Year.

Tim received his S.B. and M.Eng. from MIT in Electrical Engineering and Computer Science, an M.D. from Harvard Medical School, and Ph.D. from the Harvard-MIT Health Sciences and Technology Medical Engineering and Medical Physics Program.